ROCK and Rho(ll) in bone marrow

Slides:

Advertisements

Similar presentations

Hematology Laboratory 1 2/4/14

Advertisements

RNA interference in biology and disease by Carol A. Sledz, and Bryan R. G. Williams Blood Volume 106(3): August 1, 2005 ©2005 by American Society.

Blood and Bone Marrow Learning Objectives

Medical Histology Lab Blood and Bone Marrow Stephen Ernst 3037 BSRB.

Increased peripheral platelet destruction and caspase-3– independent programmed cell death of bone marrow megakaryocytes in myelodysplastic patients by.

Stem cell concepts renew cancer research by John E. Dick Blood Volume 112(13): December 15, 2008 ©2008 by American Society of Hematology.

Platelet activation and inhibition in polycythemia vera and essential thrombocythemia by Carlo Patrono, Bianca Rocca, and Valerio De Stefano Blood Volume.

Phenotypic and Functional Changes Induced at the Clonal Level in Hematopoietic Stem Cells After 5-Fluorouracil Treatment by Troy D. Randall, and Irving.

Neoplastic blood cells become pluripotent

Evidence for the involvement of a hematopoietic progenitor cell in systemic mastocytosis from single-cell analysis of mutations in the c-kit gene by A.

Triple play of H pylori in ITP

Polyphosphates rock! A role in thrombosis?

by Henrik Frederiksen, and Kai Schmidt

Platelet Antibody Testing in Idiopathic Thrombocytopenic Purpura

Combination of 4Ts score and PF4/H-PaGIA for diagnosis and management of heparin-induced thrombocytopenia: prospective cohort study by Lori-Ann Linkins,

by Timothy P. Hughes, and David M. Ross

by Mawadda Alnaeeli, and Yen-Tung A. Teng

Knocking out the PCFT by Donald W. Jacobsen Blood

An endothelial metronome breast cancer?

In utero transplantation may soon be in delivery

A Clinical Evaluation of the International Lymphoma Study Group Classification of Non-Hodgkin's Lymphoma Blood Volume 89(11): June 1, 1997 ©1997.

“Radical” model of thrombosis

Glis: novel modulators of TCR signaling?

BTK inhibition in myeloma: targeting the seed and the soil

Transplants for the elderly in myeloma

Sitosterolemia: platelets on high-sterol diet

Mechanisms of HIV-associated lymphocyte apoptosis

Mutagenic potential of temozolomide in bone marrow cells in vivo

by Karthik A. Ganapathi, Danielle M. Townsley, Amy P. Hsu, Diane C

SOX11 holds mantle cell lymphoma’s key to home

Inherited DDX41 mutations: 11 genes and counting

Striking Predictive Power For Relapse and Decreased Survival Associated With Detectable Minimal Residual Disease by IGH VDJ Deep Sequencing Of Bone Marrow.

What is a true ALCL? by Wolfram Klapper Blood Volume 124(9):

Acute promyelocytic leukemia, microgranular variant

Thrombin generation: biochemical possibilities and clinical reality

Setting the table for macrophages

Taking a leaf from the book of oral tolerance

by Douglas D. Ross, Judith E. Karp, Tar T. Chen, and L. Austin Doyle

Stage C or not stage C…? by Claire Dearden Blood

Blocking VWF platelet binding to treat TTP

Latest lymphoma classification is skin deep

Yang et al. SALL4 is a key regulator of survival and apoptosis in human leukemic cells. Blood. 2008;112(3):805–813. Blood Volume 114(14): October.

Splicing Misplaced Cell

Long-term acquisition of allergen-specific IgE and asthma following allogeneic bone marrow transplantation from allergic donors by Teal S. Hallstrand,

Eltrombopag for Treatment of Thrombocytopenia after Allogeneic Hematopoietic Cell Transplantation Takashi Tanaka, Yoshihiro Inamoto, Takuya Yamashita,

Platelets, On Your Marks, Get Set, Migrate!

Late-Onset Colitis after Cord Blood Transplantation Is Consistent with Graft-Versus-Host Disease: Results of a Blinded Histopathological Review Filippo.

by Geling Li, Emily Waite, and Julie Wolfson

Disparity in Survival Outcome after Hematopoietic Stem Cell Transplantation for Hematologic Malignancies According to Area of Primary Residence Keshav.

Allogeneic Stem Cell Transplantation for Aplastic Anemia

Richard Mitchell, John E. Wagner, Claudio Brunstein, Qing Cao, David H

Name that bone....

Systemic Toxoplasmosis Post Allogeneic Stem Cell Transplantation (Allo-SCT): Lessons Learned from HIV? Marie von Lilienfeld-Toal, MD, Maria Gilleece,

Kinase signaling and targeted therapy for primary myelofibrosis

Blood and Marrow Transplant Handbook

Treatment versus Transplant for Challenging Hematologic Disorders

Megakaryocytes predominantly enter the circulation as a large protrusion. Megakaryocytes predominantly enter the circulation as a large protrusion. (A)

Model depicting collagen types and collagen receptors during megakaryocyte maturation in bone marrow and proplatelet formation. Model depicting collagen.

Resistance mechanism for ibrutinib in marginal zone lymphoma

Rituximab immunotherapy: it’s getting personal

How I treat heparin-induced thrombocytopenia and thrombosis

A binding relationship with thrombin

In Memoriam: E. Donnall Thomas

Pure red cell aplasia by Robert T. Means Blood

Suggested algorithm for bone marrow biopsy and skeletal imaging in patients with monoclonal gammopathy of undetermined significance. #Mayo Clinic Risk.

by Lucy A. Godley, and Akiko Shimamura

A Novel Risk Assessment Model to Predict Venous Thromboembolism (VTE) in Cancer Inpatients: The Canclot Score by Dana E. Angelini, M. Todd Greene, Julie.

Initial treatment of CLL: integrating biology and functional status

Shifts in site of hematopoiesis during mouse and human development.

Stem cell transplant in MF: it’s time to personalize

Presentation transcript:

ROCK and Rho(ll) in bone marrow by Alan T. Nurden Blood Volume 110(1):5-6 July 1, 2007 ©2007 by American Society of Hematology

Positive and negative regulators in the bone marrow may determine the time and place of proplatelet formation in mature megakaryocytes and strategically control platelet production. Positive and negative regulators in the bone marrow may determine the time and place of proplatelet formation in mature megakaryocytes and strategically control platelet production. Alan T. Nurden Blood 2007;110:5-6 ©2007 by American Society of Hematology